DT Cloud Star Acquisition Corp announced a business combination agreement with biotech firm PrimeGen US, Inc. to take the company public via a SPAC deal. The company also addressed Nasdaq listing compliance issues by transferring to the Nasdaq Capital Market in July 2026.

• On February 2, 2026, DT Cloud Star Acquisition Corp entered into a Business Combination Agreement with PrimeGen US, Inc., a biotech firm, to effect a business combination [N1][S1].
• The company faced Nasdaq listing compliance challenges in early 2026 but successfully transferred its listing to the Nasdaq Capital Market in July 2026, regaining compliance [S2].

The company’s management team has extensive experience and a strong network that can facilitate sourcing and closing attractive business combinations. The recent Business Combination Agreement with PrimeGen, a biotech firm, represents a concrete step toward completing a transaction. The company’s public listing provides a platform for target companies to access capital markets efficiently. The management’s focus on targets with recurring revenue, defensible market positions, and growth potential aligns with creating shareholder value. The transfer to the Nasdaq Capital Market and regained compliance supports continued market access and liquidity.

The company has not yet completed a business combination, and there is no assurance that a definitive agreement will be consummated. The low current ratio and limited cash on hand may constrain operational flexibility. The company faced Nasdaq listing compliance challenges, indicating potential risks in maintaining market listing status. The broad acquisition criteria and lack of industry/geographic focus may dilute strategic clarity. Risks inherent in early-stage or growth companies targeted may impact the success of the business combination. Market conditions and shareholder approval requirements add uncertainty to transaction completion.

As a blank check company, DT Cloud Star Acquisition Corp’s moat is primarily derived from its management team’s experience, industry relationships, and ability to source and execute business combinations. The management’s track record in private equity and capital markets, combined with access to a broad network of corporate executives, venture capitalists, and private equity firms, provides differentiated deal sourcing capabilities. The company’s flexibility in structuring transactions and its public listing status offer potential advantages to target businesses seeking an alternative to traditional IPOs. However, as a SPAC without an operating business, its competitive advantage depends heavily on successful identification and execution of a value-accretive business combination.

• Nasdaq Listing Compliance Risk: The company faced Nasdaq listing compliance issues in early 2026, including failure to meet minimum market value and shareholder requirements. Although it transferred to the Nasdaq Capital Market in July 2026 and regained compliance, there is no assurance it will maintain compliance in the future. Delisting could materially reduce stock liquidity and adversely affect market price.
• Business Combination Execution Risk: There is no guarantee that the company will successfully identify, negotiate, and consummate a business combination. The process depends on multiple factors including definitive agreement execution, satisfaction of closing conditions, and shareholder approval.
• Financial Liquidity Risk: As of June 30, 2026, the company’s current ratio is low (0.04), indicating limited short-term liquidity. This may constrain operational flexibility prior to completing a business combination.
• Target Company Risk: The company may acquire businesses in early stages of development or growth, which carry inherent operational and market risks. The broad acquisition criteria may increase exposure to diverse risks depending on the target’s industry and market conditions.

• DT Cloud Star Acquisition Corp is a blank check company incorporated in the Cayman Islands on November 29, 2022, formed to effect a business combination with one or more target businesses.
• The company completed its IPO on July 26, 2024, raising gross proceeds of $69 million, with an additional private placement of $2.07 million from its sponsor.
• The IPO units trade on Nasdaq under the symbol DTSQU; ordinary shares and rights trade under DTSQ and DTSQR respectively.
• The management team is led by CEO Sam Zheng Sun, who has extensive private equity and investment experience in Asia and capital markets.
• The company seeks acquisition targets without limitation on industry or geography, focusing on businesses with strong growth prospects, defensible market positions, and recurring revenue.
• The acquisition strategy emphasizes leveraging management's operational expertise, deal execution capabilities, and broad industry relationships to identify and complete transactions.
• The company has not yet completed a business combination but entered a Business Combination Agreement on February 2, 2026, with PrimeGen US, Inc., a biotech firm.
• Financial snapshot as of June 30, 2026, shows cash and equivalents of $341,000, current assets of $45.35 million, and current liabilities of $1.03 million, resulting in a current ratio of 0.04 and cash ratio of 0.
• Net income reported for the period ending June 30, 2026, was $35,535.
• Basic and diluted EPS were -$0.028 as of June 30, 2024.
• The company faced Nasdaq listing compliance issues in early 2026 but successfully transferred its listing to the Nasdaq Capital Market in July 2026, regaining compliance.
• Recent news includes the announcement of PrimeGen going public via the SPAC deal with DT Cloud Star Acquisition Corp, reported on February 4, 2026.